肝病指南

订阅

MedSci主页 / 所有栏目 / 肝病指南

2020 BSG指南：经颈静脉肝内门体静脉内支架分流术（TIPSS）治疗门脉高压

2020-02-29 英国胃肠病学会 Gut.2020 Feb 29;

门脉高压TIPSS

2020年2月，英国胃肠病学会(BSG)发布了经颈静脉肝内门脉分流术（TIPS）治疗门脉高压指南，文章的主要目的是针对TIPSS的应用提供指导，内容涉及适应证，患者选择，操作细节，并发症以及研究议题等

中文标题：

2020 BSG指南：经颈静脉肝内门体静脉内支架分流术（TIPSS）治疗门脉高压

发布机构：

英国胃肠病学会

发布日期：

2020-02-29

简要介绍：

2020年2月，英国胃肠病学会(BSG)发布了经颈静脉肝内门脉分流术（TIPS）治疗门脉高压指南，文章的主要目的是针对TIPSS的应用提供指导，内容涉及适应证，患者选择，操作细节，并发症以及研究议题等。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 BSG指南：经颈静脉肝内门体静脉内支架分流术（TIPSS）治疗门脉高压.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e8de51c001915841, title=2020 BSG指南：经颈静脉肝内门体静脉内支架分流术（TIPSS）治疗门脉高压, enTitle=, guiderFrom=Gut.2020 Feb 29;, authorId=0, author=, summary=2020年2月，英国胃肠病学会(BSG)发布了经颈静脉肝内门脉分流术（TIPS）治疗门脉高压指南，文章的主要目的是针对TIPSS的应用提供指导，内容涉及适应证，患者选择，操作细节，并发症以及研究议题等, cover=https://img.medsci.cn/202068/1591549752409_2020535.jpg, journalId=0, articlesId=null, associationId=265, associationName=英国胃肠病学会, associationIntro=英国胃肠病学会（The British Society of Gastroenterology，BSG）专注于提升英国胃肠病学医疗水平，其涉及内科、外科、病理、放射、科学、护理、营养等领域。指南可以按日期、及专科浏览。, copyright=0, guiderPublishedTime=Sat Feb 29 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年2月，英国胃肠病学会(BSG)发布了经颈静脉肝内门脉分流术（TIPS）治疗门脉高压指南，文章的主要目的是针对TIPSS的应用提供指导，内容涉及适应证，患者选择，操作细节，并发症以及研究议题等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=3446, tagName=门脉高压), TagDto(tagId=103983, tagName=TIPSS)], categoryList=[CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3446, guiderKeyword=门脉高压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6600, appHits=278, showAppHits=0, pcHits=965, showPcHits=6322, likes=1, shares=26, comments=9, approvalStatus=1, publishedTime=Mon Jun 08 01:19:16 CST 2020, publishedTimeString=2020-02-29, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Jun 08 01:09:17 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Fri Jan 05 15:41:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 BSG指南：经颈静脉肝内门体静脉内支架分流术（TIPSS）治疗门脉高压.pdf)])
2020 BSG指南：经颈静脉肝内门体静脉内支架分流术（TIPSS）治疗门脉高压.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1061262, encodeId=536910612625d, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21e45638530, createdName=ms7000001457027556, createdTime=Sun Oct 17 17:26:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011743, encodeId=cc7b1011e4390, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:57:58 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951495, encodeId=6ed095149599, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b324c60ab184461fa91b824c5db02298/254c8a5b55974195b95c54b0e4a5cdc0.jpg, createdBy=68d882395, createdName=sanchi2013, createdTime=Fri Mar 26 23:10:22 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907584, encodeId=f36990e584f6, content=可以分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb85439678, createdName=ms7000001053200935, createdTime=Sun Dec 13 12:16:00 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899866, encodeId=c6f58998669d, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/6239c92bd2854fc184f98af3b3c328e6/4144d0a94a5544889b3b0dc7a0287a0b.jpg, createdBy=24da2298559, createdName=Shinn梦, createdTime=Tue Nov 17 14:29:22 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2021-10-17 ms7000001457027556

    好文

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1061262, encodeId=536910612625d, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21e45638530, createdName=ms7000001457027556, createdTime=Sun Oct 17 17:26:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011743, encodeId=cc7b1011e4390, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:57:58 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951495, encodeId=6ed095149599, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b324c60ab184461fa91b824c5db02298/254c8a5b55974195b95c54b0e4a5cdc0.jpg, createdBy=68d882395, createdName=sanchi2013, createdTime=Fri Mar 26 23:10:22 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907584, encodeId=f36990e584f6, content=可以分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb85439678, createdName=ms7000001053200935, createdTime=Sun Dec 13 12:16:00 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899866, encodeId=c6f58998669d, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/6239c92bd2854fc184f98af3b3c328e6/4144d0a94a5544889b3b0dc7a0287a0b.jpg, createdBy=24da2298559, createdName=Shinn梦, createdTime=Tue Nov 17 14:29:22 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2021-08-26 ms2000002074214464

    好文

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1061262, encodeId=536910612625d, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21e45638530, createdName=ms7000001457027556, createdTime=Sun Oct 17 17:26:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011743, encodeId=cc7b1011e4390, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:57:58 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951495, encodeId=6ed095149599, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b324c60ab184461fa91b824c5db02298/254c8a5b55974195b95c54b0e4a5cdc0.jpg, createdBy=68d882395, createdName=sanchi2013, createdTime=Fri Mar 26 23:10:22 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907584, encodeId=f36990e584f6, content=可以分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb85439678, createdName=ms7000001053200935, createdTime=Sun Dec 13 12:16:00 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899866, encodeId=c6f58998669d, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/6239c92bd2854fc184f98af3b3c328e6/4144d0a94a5544889b3b0dc7a0287a0b.jpg, createdBy=24da2298559, createdName=Shinn梦, createdTime=Tue Nov 17 14:29:22 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2021-03-26 sanchi2013

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1061262, encodeId=536910612625d, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21e45638530, createdName=ms7000001457027556, createdTime=Sun Oct 17 17:26:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011743, encodeId=cc7b1011e4390, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:57:58 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951495, encodeId=6ed095149599, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b324c60ab184461fa91b824c5db02298/254c8a5b55974195b95c54b0e4a5cdc0.jpg, createdBy=68d882395, createdName=sanchi2013, createdTime=Fri Mar 26 23:10:22 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907584, encodeId=f36990e584f6, content=可以分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb85439678, createdName=ms7000001053200935, createdTime=Sun Dec 13 12:16:00 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899866, encodeId=c6f58998669d, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/6239c92bd2854fc184f98af3b3c328e6/4144d0a94a5544889b3b0dc7a0287a0b.jpg, createdBy=24da2298559, createdName=Shinn梦, createdTime=Tue Nov 17 14:29:22 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-12-13 ms7000001053200935

    可以分享吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1061262, encodeId=536910612625d, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21e45638530, createdName=ms7000001457027556, createdTime=Sun Oct 17 17:26:50 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011743, encodeId=cc7b1011e4390, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:57:58 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951495, encodeId=6ed095149599, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201119/b324c60ab184461fa91b824c5db02298/254c8a5b55974195b95c54b0e4a5cdc0.jpg, createdBy=68d882395, createdName=sanchi2013, createdTime=Fri Mar 26 23:10:22 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907584, encodeId=f36990e584f6, content=可以分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb85439678, createdName=ms7000001053200935, createdTime=Sun Dec 13 12:16:00 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899866, encodeId=c6f58998669d, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/6239c92bd2854fc184f98af3b3c328e6/4144d0a94a5544889b3b0dc7a0287a0b.jpg, createdBy=24da2298559, createdName=Shinn梦, createdTime=Tue Nov 17 14:29:22 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-11-17 Shinn梦

    感谢分享

    0

拓展阅读

门脉高压患者门体支架植入围术期营养管理专家共识（2020）

中国医师协会介入医师分会 · 2021-03-28

AISF临床实践指南：门脉高压和腹水

意大利肝病学会(AISF,Italian Association for the Study of the Liver) · 2021-07-25

2021 AISF临床实践指南：门脉高压和腹水

意大利肝病学会(AISF,Italian Association for the Study of the Liver) · 2021-09-05

Baveno第七届共识会议建议：肝硬化门脉高压诊断和管理的最新进展

西班牙消化病理学会（Spanish Society of Digestive Pathology） · 2022-08-26